SCHEMBL9274756

SCHEMBL9274756

COc1cccc(C(=O)N(C)[C@H](CN2CCCC(F)(F)C2)C(C)C)c1

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ ADORA2A P29274 1/20 0.43
▸ ADORA1 P30542 1/20 0.43
▸ CHRNA1 P02708 1/20 0.42
▸ CHRNG P07510 1/20 0.42
▸ CHRNB1 P11230 1/20 0.42
▸ CHRNB2 P17787 1/20 0.42
▸ SLC6A2 P23975 1/20 0.42
▸ CHRNB4 P30926 1/20 0.42
▸ CHRNA3 P32297 1/20 0.42
▸ CHRNA4 P43681 1/20 0.42
▸ SLC6A3 Q01959 1/20 0.42
▸ CHRND Q07001 1/20 0.42
▸ NPSR1 Q6W5P4 1/20 0.41
▸ USP2 O75604 2/20 0.41
▸ CYP3A4 P08684 2/20 0.41
▸ DRD4 P21917 1/20 0.40
▸ KDM2B Q8NHM5 4/20 0.40
▸ OPRK1 P41145 1/20 0.40
▸ ALDH1A1 P00352 1/20 0.39
▸ CYP2D6 P10635 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9099249 0.84 CYP3A4 (0.38) USP2CYP3A4CYP2D6TSHR
SCHEMBL9099255 0.84 CYP3A4 (0.38) USP2CYP3A4CYP2D6TSHR
SCHEMBL9106912 0.82 ALDH1A1 (0.37) USP2CYP3A4KDM2BALDH1A1CYP2D6
SCHEMBL9106904 0.82 ALDH1A1 (0.37) USP2CYP3A4KDM2BALDH1A1CYP2D6
SCHEMBL9289051 0.82 CYP3A4 (0.40) USP2CYP3A4ALDH1A1CYP2D6TSHR
SCHEMBL9277007 0.81 DRD4 (0.41) CHRNA1CHRNGCHRNB1CHRNB2SLC6A2
SCHEMBL9276998 0.81 DRD4 (0.41) CHRNA1CHRNGCHRNB1CHRNB2SLC6A2
SCHEMBL9103967 0.80 OPRD1 (0.37) USP2CYP3A4CYP2D6
SCHEMBL9103958 0.80 OPRD1 (0.37) USP2CYP3A4CYP2D6
SCHEMBL9103975 0.80 HTR1A (0.40) —

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2012074469-A1 NEW IKACH BLOCKERS ASTRAZENECA AB (SE) 2012-06-07 — — WO disclosed
Send feedback